EBV、低维生素D、低日照与HLA-DRB1*1501通过共同表观遗传通路影响多发性硬化发病
两项病例对照研究(澳大利亚Ausimmune 206例病例+348对照;瑞典EIMS 140例病例+139对照)采用Illumina芯片检测DNA甲基化,降维生成MS相关DNAm模块并行通路富集与中介分析。结果显示EBV指标、较低25(OH)D、低日照及HLA-DRB1*1501单独及联合与MS风险相关,各研究均发现2个DNAm模块介导多种暴露-MS关联,中介比例为Ausimmune 21%–47%、EIMS 25%–53%。结论认为上述因素通过共同表观遗传通路协同影响MS发病。
要点
- EBV指标、低25(OH)D、低日照与HLA-DRB1*1501单独及联合与MS风险相关。
- 两研究各识别2个DNAm模块,中介比例为21%–47%(Ausimmune)和25%–53%(EIMS)。
- DNAm模块富集通路在两研究间有45%重叠(4.82倍,p<0.001)。
核心结论
- EBV、较低维生素D、低日照和HLA-DRB1*1501风险变异通过共同表观遗传通路协同影响MS发病风险。
研究设计与样本
- 两项病例对照研究:Ausimmune Study(澳大利亚,206例病例+348对照)和EIMS(瑞典,140例病例+139对照)。
- DNAm用Illumina芯片检测,降维方法生成MS相关DNAm模块,并行通路富集和中介分析。
主要发现
- EBV指标(传染性单核细胞增多症史和抗EBNA IgG滴度)、较低25(OH)D、低日照和HLA-DRB1*1501风险变异单独及联合与MS风险相关。
- 每项研究均发现2个DNAm模块介导多种暴露-MS关联,中介比例Ausimmune为21%–47%,EIMS为25%–53%。
- Ausimmune两个DNAm模块中GWAS顶级MS风险相关基因过代表:A1为3.5倍(p=0.004),A2为3倍(p=0.015)。
- Ausimmune DNAm模块富集的Reactome通路有45%也在EIMS中富集(4.82倍,p<0.001)。
临床怎么用
- 提示EBV感染、维生素D水平、日照暴露与遗传风险可通过DNA甲基化通路共同评估MS发病风险。
- DNAm模块及富集通路或可作为整合环境与遗传因素的分子分层线索。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Multiple sclerosis (MS) onset risk factors include Epstein-Barr virus (EBV) indices (including host response), lower serum 25-vitamin D (25(OH)D) levels, low sun exposure, and HLA-DRB1*1501. The underlying molecular mechanisms are unclear. Here, we examined mediation through differential DNA methylation (DNAm) to better understand possible epigenetic programming. METHODS: Two case-control studies (Ausimmune Study, Australia = 206 cases + 348 controls; and Epidemiologic Investigations of MS [EIMS], Sweden = 140 cases + 139 controls). DNAm was measured using Illumina arrays. Dimension-reduction methods generated MS-associated DNAm modules. Pathway enrichment analyses were used to describe DNAm modules' system-level biological characteristics. Individual and joint associations with MS risk were assessed using logistic regression. DNAm module mediation of risk factor-outcome associations were assessed using mediation analysis. A range of temporality analyses were used. RESULTS: EBV indices (infectious mononucleosis history and anti-EBNA IgG titer), lower 25(OH)D, low sun exposure, and HLA-DRB1*1501 risk variant were individually and jointly associated with MS risk. In each study, 2 DNAm modules were found which mediated multiple exposure-MS associations. Proportions mediated ranged from 21 to 47% in Ausimmune and 25 to 53% in EIMS. Results were robust to sensitivity analyses. Top-ranked genomewide association study (GWAS) MS risk-associated genes were over-represented in both Ausimmune DNAm modules, A1 3.5-fold (p = 0.004) and A2 3-fold (p = 0.015). Reactome pathways enriched for DNAm had cross-study overlap - 45% of pathways enriched in Ausimmune DNAm modules were also enriched in EIMS (4.82-fold, p < 0.001). INTERPRETATION: EBV, lower vitamin D, low sun exposure, and HLA-DRB1*1501 risk variant act in concert and through common epigenetic pathways to impact MS onset risk. ANN NEUROL 2026;99:341-355.
引用
- Simpson-Yap S, Morwitch E, Tanner SA, et al. Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset. Ann Neurol. 2025. PMID: 41070760. doi:10.1002/ana.78043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。